Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 26, Issue 11, 2010, Pages 815-818

  Selcoki, Yusuf ^a   Yilmaz, Omer Caglar ^a   Carlioglu, Ayse ^a   Onaran, Yuksel ^a   Nur Kankilic, Makbule ^a   Karakurt, Feridun ^a   Eryonucu, Beyhan ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

echocardiography; Polycystic ovary syndrome; tissue Doppler

Indexed keywords

FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART DISEASES; HUMANS; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; YOUNG ADULT;

EID: 77957973660     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.487596     Document Type: Article

References (23)

1. Ehrmann DA. Polycystic ovary syndrome. N Eng J Med 2005; 352:1223-1236.
2. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005;83:1343-1346.
3. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycysic ovary syndrome? Best Pract Res Clin Obstet Gynecol 2004;18:671-683.
4. Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C. Cardiovascular risk in women polycystic ovary syndrome. J Cardiovasc Med 2008;9:987-992.
5. Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE. Menstrual cycle irregularity and risk for future cardiovascular disease. Fertil Steril 2002;87:2013-2017.
6. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Shan D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiography 1989;2:358-367.
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
8. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83:2694-2698.
9. Franks S. Are women with polycystic ovary syndrome at increased risk of cardiovascular disease? Too early to be sure, but not too early to act! Am J Med 2001;11:665-666.
10. Legro RS, Kunselman AR, Dunaif A. Prevalance and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607-613.
11. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992;37: 119-125.
12. Yarali H, Yildirir A, Aybar F, Kabakci G, Bükulmez O, Akgül E, Oto A. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001;76:511-516.
13. Topcu S, Caliskan M, Ozcimen EE, Tok D, Uckuyu A, Erdogan D, Gullu H, Yildirir A, Zeyneloglu H, Muderrisoglu H. Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease? Hum Reprod 2006;21:930-935.
14. Jialal I, Naiker P, Reddi K, Moodley J, Joubert SM. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987;64:1066-1069.
15. Gennarelli G, Holte J, Berglund L, Berne C, Massobrio M, Lithell H. Prediction models for insulin resistance in the polycystic ovary syndrome. Hum Reprod 2000;15:2098-2102.
16. Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljon M, Gorlin R, Krakoff LR. polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992;75:508-513.
17. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 1998;51:415-422.
18. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JU, Remsberg KE, Kuller LH. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-age women. Arterioscler Thromb Vasc Biol 2000;20:2414-2421.
19. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001; 103:1410-1415.
20. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562-2568.
21. Lin S, Tak T, Kawanish DT, Mckay CR, Rahimtoola SH, Chandroratna PA. Comparison of Doppler echocardio-graphic and hemodynamic index of left ventricular diastolic properties in coronary artery disease. Am J Cardiol 1998; 62:882-886.
22. Tiras MB, Yalcin R, Noyan V, Maral I, Yildirim M, Dortlemez O, Daya S. Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 1999;14:1949-1952.
23. Tekin A, Tekin G, Colkesen Y, Klcdag EB, Bashan I, Sezgin AT, Muderrisoglu Het. Left ventricular function in patients with polycystic ovary syndrome: A Doppler echocar-diographic study. Exp Clin Endocrinol Diabetes 2009; 117:165-169.